⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 4, 2024Open Access

Figure S7 from Genetic Silencing of AKT Induces Melanoma Cell Death via mTOR Suppression

Gennie L. Parkman Tursun Turapov David A. Kircher William J. Burnett Christopher M. Stehn Kayla O’Toole Katie M. Culver Ashley T. Chadwick Riley C. Elmer Ryan Flaherty Karly A. Stanley Mona Foth David H. Lum Robert L. Judson‐Torres John E. Friend Matthew W. VanBrocklin Martin McMahon Sheri L. Holmen

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary Figure S7 shows chemical structures of all pharmacological agents utilized in study, including MK2206, GSK2141795, GDC-0941, BYL719, RapaLink-1, GSK650394, GDC-0068, GDC-0084, and INY-03-041.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Parkman et al. (2024) studied this question.

synapsesocial.com/papers/68e75dd0b6db6435876d4c16 https://doi.org/10.1158/1535-7163.25337876

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S1 from Genetic Silencing of AKT Induces Melanoma Cell Death via mTOR Suppression2024
2Figure S3 from Genetic Silencing of AKT Induces Melanoma Cell Death via mTOR Suppression2024
3Figure S2 from Genetic Silencing of AKT Induces Melanoma Cell Death via mTOR Suppression2024
4Figure S4 from Genetic Silencing of AKT Induces Melanoma Cell Death via mTOR Suppression2024
5Figure S6 from Genetic Silencing of AKT Induces Melanoma Cell Death via mTOR Suppression2024